0001474064-12-000015.txt : 20120201
0001474064-12-000015.hdr.sgml : 20120201
20120201160919
ACCESSION NUMBER: 0001474064-12-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120130
FILED AS OF DATE: 20120201
DATE AS OF CHANGE: 20120201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRATEMEIER ED
CENTRAL INDEX KEY: 0001474064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 12562729
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2012-01-30
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001474064
STRATEMEIER ED
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
SVP & General Counsel
Stock Options
3.34
2012-01-30
4
A
0
18000
0
A
2020-02-19
Common Stock
18000
18000
D
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On January 30, 2012, the performance criteria for 18,000 of these options had been satisfied because the Issuer's NDA was accepted by the FDA. These 18,000 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
Edward Stratemeier
2012-02-01